re: fda approval Thats right, it opens up all sorts of questions. Remember that coramsine did show partial responses and a long term remission out of the 6 only patients that completed the full treatment . These were late stage refractory patients for whome there was no other treatment. Depends on interpretation I guess.
One of the responses was NSCLC, the biggest killer cancer in the USA
- Forums
- ASX - By Stock
- SBP
- re: fda approval
SBP
solbec pharmaceuticals limited
re: fda approval, page-2
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
NRZ
NEURIZER LTD
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online